A comprehensive overview of advanced dynamic in vitro intestinal and hepatic cell culture models
Orally administered drugs pass through the gastrointestinal tract before being absorbed in the small intestine and metabolised in the liver. To test the efficacy and toxicity of drugs, animal models are often employed; however, they are not suitable for investigating drug-tissue interactions and making reliable predictions, since the human organism differs drastically from animals in terms of absorption, distribution, metabolism and excretion of substances. Likewise, simple static in vitro cell culture systems currently used in preclinical drug screening often do not resemble the native characteristics of biological barriers. Dynamic models, on the other hand, provide in vivo-like cell phenotypes and functionalities that offer great potential for safety and efficacy prediction. Herein, current microfluidic in vitro intestinal and hepatic models are reviewed, namely single- and multi-tissue micro-bioreactors, which are associated with different methods of cell cultivation, i.e., scaffold-based versus scaffold-free.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Tissue barriers - 12(2024), 1 vom: 02. Jan., Seite 2163820 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Leal, Filipa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bioprinting |
|---|
| Anmerkungen: |
Date Completed 01.02.2024 Date Revised 16.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/21688370.2022.2163820 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351912452 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351912452 | ||
| 003 | DE-627 | ||
| 005 | 20240216232421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/21688370.2022.2163820 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1295.xml |
| 035 | |a (DE-627)NLM351912452 | ||
| 035 | |a (NLM)36680530 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Leal, Filipa |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A comprehensive overview of advanced dynamic in vitro intestinal and hepatic cell culture models |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.02.2024 | ||
| 500 | |a Date Revised 16.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Orally administered drugs pass through the gastrointestinal tract before being absorbed in the small intestine and metabolised in the liver. To test the efficacy and toxicity of drugs, animal models are often employed; however, they are not suitable for investigating drug-tissue interactions and making reliable predictions, since the human organism differs drastically from animals in terms of absorption, distribution, metabolism and excretion of substances. Likewise, simple static in vitro cell culture systems currently used in preclinical drug screening often do not resemble the native characteristics of biological barriers. Dynamic models, on the other hand, provide in vivo-like cell phenotypes and functionalities that offer great potential for safety and efficacy prediction. Herein, current microfluidic in vitro intestinal and hepatic models are reviewed, namely single- and multi-tissue micro-bioreactors, which are associated with different methods of cell cultivation, i.e., scaffold-based versus scaffold-free | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Microfluidic devices | |
| 650 | 4 | |a bioprinting | |
| 650 | 4 | |a gastrointestinal tract | |
| 650 | 4 | |a intestine | |
| 650 | 4 | |a liver | |
| 650 | 4 | |a multi-organ-on-a-chip | |
| 700 | 1 | |a Zeiringer, Scarlett |e verfasserin |4 aut | |
| 700 | 1 | |a Jeitler, Ramona |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Pedro F |e verfasserin |4 aut | |
| 700 | 1 | |a Roblegg, Eva |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tissue barriers |d 2013 |g 12(2024), 1 vom: 02. Jan., Seite 2163820 |w (DE-627)NLM231128622 |x 2168-8370 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g number:1 |g day:02 |g month:01 |g pages:2163820 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/21688370.2022.2163820 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2024 |e 1 |b 02 |c 01 |h 2163820 | ||